Molecular Pathology Economics 101: An Overview of Molecular Diagnostics Coding, Coverage, and Reimbursement

Widespread indications for use of molecular diagnostics in various aspects of clinical medicine have driven proliferation of testing. The rapid adoption and continuous technological evolution of molecular diagnostics have often strained the development and maintenance of a functional underlying framework of coding, coverage, and reimbursement policies, thereby presenting challenges to various stakeholders, including molecular professionals, payers, and patients. A multidisciplinary working group convened by the Association for Molecular Pathology Economic Affairs Committee was tasked to describe the complex landscape of molecular pathology economics and highlight opportunities for member engagement.

Source: Journal of Molecular Diagnostics - June 1, 2020 Category: Pathology Authors: Anthony N. Sireci, Jay L. Patel, Loren Joseph, Matthew C. Hiemenz, Oana C. Rosca, Samuel K. Caughron, Sarah A. Thibault-Sennett, Tara L. Burke, Dara L. Aisner Tags: Special article Source Type: research